Norman Ramirez, MD
Cardiovascular Disease · Edinburg, TXNPI 1871532531
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,567 of the $15,815 with a category attached, or 60.5%. Abbott accounts for 61.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $5,424 and has fallen 84.9% since, to $817 in 2025.
Across 153 payments — averaging $103.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$10K
- Medtronic$3K
- Silk Road Medical, Inc.$2K
- Boston Scientific$1K
- Impulse Dynamics (USA) Inc.$94
- Arrow International, Inc.$50
- plus $56 from 3 others
Across 8 payments — averaging $5786.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cordis US CORP.$38K
- Janssen Research & Development, LLC$8K
What the payments were for
- Travel & lodging$9,56760%
- Food & beverage$6,24840%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 81 | $9,765 |
| Medtronic(2 entities) | 49 | $2,921 |
| Silk Road Medical, Inc. | 8 | $1,613 |
| Boston Scientific | 9 | $1,316 |
| Impulse Dynamics (USA) Inc. | 2 | $94 |
| Arrow International, Inc. | 1 | $50 |
| Pfizer | 1 | $24 |
| Johnson & Johnson | 1 | $21 |
| Angiodynamics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$2,973
- Mitra Clip system$2,342
- ENROUTE Transcarotid Neuroprotection System$1,721
- ENROUTE Transcarotid Stent$1,577
- Watchman$1,135
- COREVALVE EVOLUT R$1,081
- Cardiovascular- Research only$1,025
- Micra$447
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$144
- Fortify Assura, Ellipse ICD$132
- Quadra Assura CRT Defibrillator$119
- CoreValve Evolut$104
- Assurity Pacemaker$101
How this compares
$15,815 in reported general payments places this provider in the 85th percentile of 1,515 cardiovascular disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 87 | $1,365 |
| Cephalexin | 29 | $182 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Edinburg
- Ramin Farzaneh-FarDallas$17.1M
- John OsborneGrapevine$1.3M
- Darren McGuireDallas$1.2M
- Peter McCulloughDallas$664K
- Ann NavarDallas$616K
- Biykem BozkurtHouston$606K
- Milton PackerDallas$530K
- Amarinder BindraDallas$512K
- Robert SalazarKingwood$478K
- Reynolds DelgadoHouston$471K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.